BR9609413A - Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais - Google Patents

Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais

Info

Publication number: BR9609413A
Authority: BR; Brazil
Prior art keywords: prophylaxis; treatment; gastrointestinal disorders; dietary; pct
Prior art date: 1995-06-23

Application number

BR9609413A

Other languages

English (en)

Inventor

Haen Christoph De

Luigia Gozzini

Original Assignee

Bracco Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-23

Filing date

1996-06-19

Publication date

1999-05-18

1996-06-19 Application filed by Bracco Spa filed Critical Bracco Spa

1999-05-18 Publication of BR9609413A publication Critical patent/BR9609413A/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Mycology (AREA)
Chemical & Material Sciences (AREA)
Microbiology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Nutrition Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Confectionery (AREA)
Seasonings (AREA)
Medicines Containing Plant Substances (AREA)
Non-Alcoholic Beverages (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BR9609413A 1995-06-23 1996-06-19 Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais BR9609413A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT95MI001359A IT1276783B1 (it)	1995-06-23	1995-06-23	Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
PCT/EP1996/002650 WO1997000688A1 (en)	1995-06-23	1996-06-19	Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders

Publications (1)

Publication Number	Publication Date
BR9609413A true BR9609413A (pt)	1999-05-18

Family

ID=11371866

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9609413A BR9609413A (pt)	1995-06-23	1996-06-19	Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais

Country Status (18)

Country	Link
US (1)	US6007808A (pt)
EP (1)	EP0833644B1 (pt)
JP (1)	JPH11507934A (pt)
CN (1)	CN1082373C (pt)
AT (1)	ATE234623T1 (pt)
AU (1)	AU707399B2 (pt)
BR (1)	BR9609413A (pt)
CA (1)	CA2219739A1 (pt)
DE (2)	DE833644T1 (pt)
DK (1)	DK0833644T3 (pt)
ES (1)	ES2194107T3 (pt)
HU (1)	HUP9901707A3 (pt)
IT (1)	IT1276783B1 (pt)
MX (1)	MX9709238A (pt)
NO (1)	NO976048L (pt)
NZ (1)	NZ312121A (pt)
WO (1)	WO1997000688A1 (pt)
ZA (1)	ZA965235B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020035071A1 (en) *	1997-07-08	2002-03-21	Josef Pitha	Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en)	1997-07-08	2013-10-22	The Iams Company	Method of maintaining and/or attenuating a decline in quality of life
US20060116330A1 (en) *	1997-07-08	2006-06-01	The Iams Company	Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20040166101A1 (en) *	1999-09-22	2004-08-26	Bojrab Gregory G.	Enchanced composition for treatment of gastrointestinal disorders and hyperlipidemia
US6641808B1 (en) *	1999-09-22	2003-11-04	Lacpro Industries, Llc	Composition for treatment of obesity
WO2001083700A2 (en) *	2000-05-03	2001-11-08	University Of Maryland, Baltimore	Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal
US7112570B2 (en) *	2000-08-24	2006-09-26	Neuren Pharmaceuticals, Ltd.	GPE analogs
US6864242B2 (en)	2001-03-05	2005-03-08	Stephen P. Ernest	Enteral formulation
TWI351278B (en) *	2002-03-01	2011-11-01	Nisshin Pharma Inc	Agent for preventing and treating of liver disease
JP4559380B2 (ja) *	2002-03-01	2010-10-06	日清ファルマ株式会社	肝疾患治療剤
US20060127378A1 (en) *	2002-07-22	2006-06-15	Kenji Yasuda	Composition for promoting the proliferation of lactobacillus casei subsp. casei
DK175877B1 (da) *	2002-11-11	2005-05-09	Pharmalett As	Præparater til anvendelse som terapeutisk middel
WO2005000034A2 (en) *	2003-06-23	2005-01-06	Agtech Products, Inc.	Lactic bacteria and its use in direct-fed microbials
US20050100559A1 (en) *	2003-11-07	2005-05-12	The Procter & Gamble Company	Stabilized compositions comprising a probiotic
US20050158294A1 (en) *	2003-12-19	2005-07-21	The Procter & Gamble Company	Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) *	2003-12-19	2014-11-25	The Iams Company	Canine probiotic Lactobacilli
US8877178B2 (en) *	2003-12-19	2014-11-04	The Iams Company	Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en)	2003-12-19	2005-07-14	The Procter & Gamble Company	Canine probiotic Bifidobacteria globosum
US7785635B1 (en)	2003-12-19	2010-08-31	The Procter & Gamble Company	Methods of use of probiotic lactobacilli for companion animals
CA2609617C (en) *	2005-05-31	2014-07-08	The Iams Company	Feline probiotic lactobacilli
AU2006253007B2 (en) *	2005-05-31	2012-12-20	Alimentary Health Ltd	Feline probiotic Bifidobacteria
JPWO2007119502A1 (ja) *	2006-03-23	2009-08-27	協和発酵バイオ株式会社	便通改善剤
WO2007126990A2 (en) *	2006-03-29	2007-11-08	Nestec S.A.	Dietary supplements containing probiotics
RU2436581C2 (ru)	2007-02-01	2011-12-20	Дзе Иамс Компани	Способ уменьшения воспаления и снижения стресса у млекопитающего
CN101259140B (zh) *	2007-03-08	2012-08-22	重庆北碚现代应用药物研究所	一种治疗胃炎、胃溃疡及十二指肠溃疡的复方药物及其制备方法
CN101273736B (zh) *	2007-03-28	2012-08-08	北京弗蒙特生物技术有限公司	一种在常温下保持高活菌数的发酵乳的制备方法
US9771199B2 (en)	2008-07-07	2017-09-26	Mars, Incorporated	Probiotic supplement, process for making, and packaging
EP2206506A1 (en) *	2008-12-18	2010-07-14	Bracco Imaging S.p.A	Probiotic formulations
WO2011009848A2 (en)	2009-07-20	2011-01-27	Bracco Spa	Therapeutic use of probiotics
US10104903B2 (en)	2009-07-31	2018-10-23	Mars, Incorporated	Animal food and its appearance
US9856451B2 (en)	2011-12-28	2018-01-02	Yamada Bee Company Inc.	Lactic acid bacterium having IgA production promoting activity, and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4839281A (en) *	1985-04-17	1989-06-13	New England Medical Center Hospitals, Inc.	Lactobacillus strains and methods of selection
US5397803A (en) *	1985-09-12	1995-03-14	Brigham And Women's Hospital	Use of glutamine to reduce rate of pathogenic microorganism infection
JPH0367046A (ja) *	1989-08-05	1991-03-22	Mitsubishi Motors Corp	エンジンの吸入空気量制御装置
CN1105544A (zh) *	1994-09-09	1995-07-26	扬州大学农学院	一种制取活性乳酸菌口服液的方法
US5531681A (en) *	1995-01-13	1996-07-02	Abbott Laboratories	Apparatus for altering composition of nutritional product during enteral tube feeding

1995
- 1995-06-23 IT IT95MI001359A patent/IT1276783B1/it active IP Right Grant
1996
- 1996-06-19 AT AT96922842T patent/ATE234623T1/de not_active IP Right Cessation
- 1996-06-19 DE DE0833644T patent/DE833644T1/de active Pending
- 1996-06-19 ES ES96922842T patent/ES2194107T3/es not_active Expired - Lifetime
- 1996-06-19 HU HU9901707A patent/HUP9901707A3/hu unknown
- 1996-06-19 JP JP9503576A patent/JPH11507934A/ja active Pending
- 1996-06-19 NZ NZ312121A patent/NZ312121A/xx unknown
- 1996-06-19 DE DE69626818T patent/DE69626818T2/de not_active Expired - Lifetime
- 1996-06-19 WO PCT/EP1996/002650 patent/WO1997000688A1/en not_active Ceased
- 1996-06-19 US US08/973,676 patent/US6007808A/en not_active Expired - Lifetime
- 1996-06-19 MX MX9709238A patent/MX9709238A/es not_active IP Right Cessation
- 1996-06-19 BR BR9609413A patent/BR9609413A/pt not_active Application Discontinuation
- 1996-06-19 CN CN96194976A patent/CN1082373C/zh not_active Expired - Fee Related
- 1996-06-19 AU AU63575/96A patent/AU707399B2/en not_active Ceased
- 1996-06-19 DK DK96922842T patent/DK0833644T3/da active
- 1996-06-19 EP EP96922842A patent/EP0833644B1/en not_active Expired - Lifetime
- 1996-06-19 CA CA002219739A patent/CA2219739A1/en not_active Abandoned
- 1996-06-20 ZA ZA965235A patent/ZA965235B/xx unknown
1997
- 1997-12-22 NO NO976048A patent/NO976048L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ITMI951359A1 (it)	1996-12-23
EP0833644A1 (en)	1998-04-08
IT1276783B1 (it)	1997-11-03
ATE234623T1 (de)	2003-04-15
ITMI951359A0 (it)	1995-06-23
DE69626818T2 (de)	2003-11-20
US6007808A (en)	1999-12-28
HUP9901707A2 (hu)	1999-09-28
JPH11507934A (ja)	1999-07-13
MX9709238A (es)	1998-03-31
CA2219739A1 (en)	1997-01-09
AU707399B2 (en)	1999-07-08
NZ312121A (en)	1999-03-29
NO976048D0 (no)	1997-12-22
HUP9901707A3 (en)	2001-04-28
EP0833644B1 (en)	2003-03-19
ZA965235B (en)	1997-01-09
CN1082373C (zh)	2002-04-10
ES2194107T3 (es)	2003-11-16
WO1997000688A1 (en)	1997-01-09
DE69626818D1 (de)	2003-04-24
AU6357596A (en)	1997-01-22
CN1188413A (zh)	1998-07-22
DE833644T1 (de)	1998-09-03
NO976048L (no)	1998-02-23
DK0833644T3 (da)	2003-07-21

Publication	Publication Date	Title
BR9609413A (pt)	1999-05-18	Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais
PT763037E (pt)	2002-05-31	Derivados de pirrol ¬a\|-anelizados e sua utilizacao farmaceutica
KR960700059A (ko)	1996-01-19	파킨슨씨 병 및 파킨슨 중후군의 치료에 카르바마제핀 및 옥스카르바제핀의 이용(application of carbamazepine and oxcarbazepine in the treatment of parkinson's disease and parkinsonian syndromes)
IL113941A (en)	2000-02-17	Perfluoroalkyl ketone inhibitors of elastase processes for making the same and pharmaceutical compositions containing them
PT741716E (pt)	2002-12-31	Analogos de delta 12,13-iso-taxol sua utilizacao anti-neoplasica e composicoes farmaceuticas que os contem
IL113566A0 (en)	1995-08-31	Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
BR0114344A (pt)	2003-07-01	Retinóides para o tratamento de enfisema
BR9509975A (pt)	1998-06-09	Formulação farmacêutica
ATE303362T1 (de)	2005-09-15	Chalcon-derivate mit antiproliferativer aktivität
AU4179399A (en)	1999-11-16	Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
ES2177024T3 (es)	2002-12-01	Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
BG108452A (en)	2005-02-28	Tablet comprising cetirizine and pseudoephedrine
MX9707642A (es)	1997-12-31	Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
DK0678089T3 (da)	1996-11-18	N-Acylpyrrolidiner og lægemidler til behandling eller forebyggelse af cholecystokinin- og gastrin-relaterede forstyrrelser
ES2188742T3 (es)	2003-07-01	Trapidil para uso en la terapia de cuadros patologicos influenciables por la inmunomodulacion.
ES2140544T3 (es)	2000-03-01	Utilizacion de efaroxan y de sus derivados para la fabricacion de medicamentos destinados al tratamiento de las enfermedades neurodegenerativas.
RU98117520A (ru)	2000-07-10	Применение ингибитора na+/h+-обменника для изготовления лекарственного препарата для лечения и профилактики заболеваний центральной нервной системы
AU5768298A (en)	1998-07-17	Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
KR960700053A (ko)	1996-01-19	방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)
MX9804579A (es)	1998-10-31	Composiciones que contienen bismuto para la prevencion y tratamiento de trastornos gastrointestinales.
BR1100506A (pt)	2004-06-08	Composição para o tratamento de um ser humano sofrendo de um distúrbio intestinal.
ECSP972296A (es)	1998-12-14	Sintesis de benzo (f) quinolinonas

Legal Events

Date	Code	Title	Description
2003-06-10	EG	Technical examination (opinion): publication of technical examination (opinion)
2006-01-10	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2006-05-23	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM O ARTIGO 8O DA LPI.